vs
Side-by-side financial comparison of CENTRAL PACIFIC FINANCIAL CORP (CPF) and Cytek Biosciences, Inc. (CTKB). Click either name above to swap in a different company.
CENTRAL PACIFIC FINANCIAL CORP is the larger business by last-quarter revenue ($72.9M vs $62.1M, roughly 1.2× Cytek Biosciences, Inc.). CENTRAL PACIFIC FINANCIAL CORP runs the higher net margin — 28.4% vs -70.9%, a 99.3% gap on every dollar of revenue. On growth, Cytek Biosciences, Inc. posted the faster year-over-year revenue change (8.1% vs 6.0%). Over the past eight quarters, Cytek Biosciences, Inc.'s revenue compounded faster (17.7% CAGR vs 6.7%).
Central Pacific Bank (CPB) is an American regional commercial bank located throughout the state of Hawaii.
Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.
CPF vs CTKB — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $72.9M | $62.1M |
| Net Profit | $20.7M | $-44.1M |
| Gross Margin | — | 52.9% |
| Operating Margin | — | -9.0% |
| Net Margin | 28.4% | -70.9% |
| Revenue YoY | 6.0% | 8.1% |
| Net Profit YoY | -9.4% | -557.1% |
| EPS (diluted) | $0.78 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $72.9M | — | ||
| Q4 25 | $76.3M | $62.1M | ||
| Q3 25 | $74.8M | $52.3M | ||
| Q2 25 | $72.8M | $45.6M | ||
| Q1 25 | $68.8M | $41.5M | ||
| Q4 24 | $58.4M | $57.5M | ||
| Q3 24 | $66.6M | $51.5M | ||
| Q2 24 | $64.0M | $46.6M |
| Q1 26 | $20.7M | — | ||
| Q4 25 | $22.9M | $-44.1M | ||
| Q3 25 | $18.6M | $-5.5M | ||
| Q2 25 | $18.3M | $-5.6M | ||
| Q1 25 | $17.8M | $-11.4M | ||
| Q4 24 | $11.3M | $9.6M | ||
| Q3 24 | $13.3M | $941.0K | ||
| Q2 24 | $15.8M | $-10.4M |
| Q1 26 | — | — | ||
| Q4 25 | — | 52.9% | ||
| Q3 25 | — | 52.7% | ||
| Q2 25 | — | 52.3% | ||
| Q1 25 | — | 48.6% | ||
| Q4 24 | — | 58.5% | ||
| Q3 24 | — | 56.3% | ||
| Q2 24 | — | 54.6% |
| Q1 26 | — | — | ||
| Q4 25 | 37.0% | -9.0% | ||
| Q3 25 | 31.6% | -17.6% | ||
| Q2 25 | 32.8% | -23.3% | ||
| Q1 25 | 32.8% | -36.1% | ||
| Q4 24 | 23.0% | 5.2% | ||
| Q3 24 | 25.6% | -8.2% | ||
| Q2 24 | 32.2% | -18.3% |
| Q1 26 | 28.4% | — | ||
| Q4 25 | 30.0% | -70.9% | ||
| Q3 25 | 24.8% | -10.5% | ||
| Q2 25 | 25.1% | -12.2% | ||
| Q1 25 | 25.8% | -27.5% | ||
| Q4 24 | 19.4% | 16.8% | ||
| Q3 24 | 20.0% | 1.8% | ||
| Q2 24 | 24.7% | -22.4% |
| Q1 26 | $0.78 | — | ||
| Q4 25 | $0.85 | — | ||
| Q3 25 | $0.69 | — | ||
| Q2 25 | $0.67 | — | ||
| Q1 25 | $0.65 | — | ||
| Q4 24 | $0.42 | — | ||
| Q3 24 | $0.49 | — | ||
| Q2 24 | $0.58 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $90.9M |
| Total DebtLower is stronger | $76.5M | — |
| Stockholders' EquityBook value | $593.9M | $341.7M |
| Total Assets | $7.5B | $461.5M |
| Debt / EquityLower = less leverage | 0.13× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | $90.9M | ||
| Q3 25 | — | $93.3M | ||
| Q2 25 | — | $75.5M | ||
| Q1 25 | — | $95.3M | ||
| Q4 24 | — | $98.7M | ||
| Q3 24 | — | $162.3M | ||
| Q2 24 | — | $177.9M |
| Q1 26 | $76.5M | — | ||
| Q4 25 | $76.5M | — | ||
| Q3 25 | $131.5M | — | ||
| Q2 25 | $131.5M | — | ||
| Q1 25 | $131.4M | — | ||
| Q4 24 | $156.3M | — | ||
| Q3 24 | $156.3M | — | ||
| Q2 24 | $156.2M | — |
| Q1 26 | $593.9M | — | ||
| Q4 25 | $592.6M | $341.7M | ||
| Q3 25 | $588.1M | $378.6M | ||
| Q2 25 | $568.9M | $377.6M | ||
| Q1 25 | $557.4M | $379.6M | ||
| Q4 24 | $538.4M | $395.7M | ||
| Q3 24 | $543.7M | $385.5M | ||
| Q2 24 | $518.6M | $389.1M |
| Q1 26 | $7.5B | — | ||
| Q4 25 | $7.4B | $461.5M | ||
| Q3 25 | $7.4B | $494.9M | ||
| Q2 25 | $7.4B | $493.3M | ||
| Q1 25 | $7.4B | $482.6M | ||
| Q4 24 | $7.5B | $499.5M | ||
| Q3 24 | $7.4B | $491.2M | ||
| Q2 24 | $7.4B | $483.7M |
| Q1 26 | 0.13× | — | ||
| Q4 25 | 0.13× | — | ||
| Q3 25 | 0.22× | — | ||
| Q2 25 | 0.23× | — | ||
| Q1 25 | 0.24× | — | ||
| Q4 24 | 0.29× | — | ||
| Q3 24 | 0.29× | — | ||
| Q2 24 | 0.30× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $-771.0K |
| Free Cash FlowOCF − Capex | — | $-1.8M |
| FCF MarginFCF / Revenue | — | -2.9% |
| Capex IntensityCapex / Revenue | — | 1.6% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-8.8M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $97.5M | $-771.0K | ||
| Q3 25 | $22.2M | $-3.9M | ||
| Q2 25 | $34.3M | $108.0K | ||
| Q1 25 | $20.4M | $-125.0K | ||
| Q4 24 | $90.5M | $2.0M | ||
| Q3 24 | $21.3M | $13.2M | ||
| Q2 24 | $25.9M | $6.2M |
| Q1 26 | — | — | ||
| Q4 25 | $92.3M | $-1.8M | ||
| Q3 25 | $21.4M | $-4.6M | ||
| Q2 25 | $32.3M | $-1.5M | ||
| Q1 25 | $19.6M | $-974.0K | ||
| Q4 24 | $75.4M | $1.1M | ||
| Q3 24 | $15.6M | $12.2M | ||
| Q2 24 | $21.3M | $5.2M |
| Q1 26 | — | — | ||
| Q4 25 | 121.0% | -2.9% | ||
| Q3 25 | 28.6% | -8.7% | ||
| Q2 25 | 44.3% | -3.2% | ||
| Q1 25 | 28.4% | -2.3% | ||
| Q4 24 | 129.2% | 1.9% | ||
| Q3 24 | 23.5% | 23.7% | ||
| Q2 24 | 33.2% | 11.0% |
| Q1 26 | — | — | ||
| Q4 25 | 6.8% | 1.6% | ||
| Q3 25 | 1.2% | 1.3% | ||
| Q2 25 | 2.7% | 3.5% | ||
| Q1 25 | 1.3% | 2.0% | ||
| Q4 24 | 25.8% | 1.6% | ||
| Q3 24 | 8.5% | 2.0% | ||
| Q2 24 | 7.3% | 2.3% |
| Q1 26 | — | — | ||
| Q4 25 | 4.26× | — | ||
| Q3 25 | 1.20× | — | ||
| Q2 25 | 1.88× | — | ||
| Q1 25 | 1.15× | — | ||
| Q4 24 | 7.98× | 0.21× | ||
| Q3 24 | 1.60× | 14.05× | ||
| Q2 24 | 1.64× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CPF
Segment breakdown not available.
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
